Episode 498 - Proteins, MRNA and fighting back against cancer

How can we develop new treatments to tackle antibiotic resistance and tumors. Antibiotics were the miracle of public health in the 20th century, but how can we establish new treatments into the 21st. Find the right protein and you can stop bacteria in its tracks by splitting it in two. New treatments can tackle antibiotic resistant bacteria by using proteins to break them in two. Cancer vaccines are benefiting from the mRNA revolution. A challenge with vaccines is that they can end up in the liver, so how do you get them to  deliver their instructions more effectively. Using special lipid nano particles, cancer mRNA vaccines can target the lymph nodes making for more powerful vaccines. Shouya Feng, Daniel Enosi Tuipulotu, Abhimanu Pandey, Weidong Jing, Cheng Shen, Chinh Ngo, Melkamu B. Tessema, Fei-Ju Li, Daniel Fox, Anukriti Mathur, Anyang Zhao, Runli Wang, Klaus Pfeffer, Daniel Degrandi, Masahiro Yamamoto, Patrick C. Reading, Gaetan Burgio, Si Ming Man. Pathogen-selective killing by guanylate-binding proteins as a molecular mechanism leading to inflammasome signaling. Nature Communications, 2022; 13 (1) DOI: 10.1038/s41467-022-32127-0 Jinjin Chen, Zhongfeng Ye, Changfeng Huang, Min Qiu, Donghui Song, Yamin Li, Qiaobing Xu. Lipid nanoparticle-mediated lymph node–targeting delivery of mRNA cancer vaccine elicits robust CD8 + T cell response. Proceedings of the National Academy of Sciences, 2022; 119 (34) DOI: 10.1073/pnas.2207841119